Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 118-125

  Greenough, Thomas C ^a   Brettler, Doreen B ^b   Somasundaran, Mohan ^b   Panicali, Dennis L ^b   Sullivan, John L ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0030917308     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514013     Document Type: Article

References (14)

1. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987;328:345-8.
2. Koup RA, Sullivan JL, Levine PH, et al. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 1989;73:1909-14.
3. Lanhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, et al. Qualitative and quantitative analysis of human cytotoxic T-Iymphocyte responses to HIV-1 proteins. AIDS 1992;6:1249-58.
4. Koup RA, Pikora CA, Luzuriaga K, et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: In vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 1991;174:1593-600.
5. Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol 1990;2:707-12.
6. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 1989;142:452-62.
7. Johnson RP, Trocha A, Yang L, et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J Immunol 1991; 147:1512-21.
8. Johnson RP, Trocha A, Buchanan TM, Walker BD. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J Exp Med 1992;175:961-71.
9. Hadida F, Parrot A, Kieny MP, et al. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest 1992;89:53-60.
10. Walker BD, Flexner C, Paradis TJ, et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 1988; 240:64-6.
11. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc Natl Acad Sci USA 1990;87:4818-22.
12. O'Toole CM, Graham S, Lowdell MW, Chargelegue D, Marsden H, Colvin BT. Decline in CTL and antibody responses to p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year study. AIDS Res Hum Retroviruses 1992;8:1361-8.
13. Rinaldo C, Huang XL, Fan Z, et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors. J Virol 1995;69:5838-42.
14. Harrer T, Harrer E, Kalams SA, et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J Immunol 1996; 156:2616-23.